Apollo Hospitals Enterprise Limited vs Supriya Lifescience Limited

A side-by-side comparison of Apollo Hospitals Enterprise Limited (APOLLOHOSP) and Supriya Lifescience Limited (SUPRIYA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

Apollo Hospitals Enterprise Limited vs Supriya Lifescience Limited are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.

  • Valuation22
  • Profitability13
  • Growth11
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

58.43
P/E ratio
34.10
13.46
P/B ratio
6.17
0.22%
Dividend yield
0.11%
₹135.04
EPS
₹25.98

Profitability

SUPRIYA takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

20.48%
Return on equity
17.46%
17.31%
Return on capital
23.00%
14.94%
EBITDA margin
35.52%
7.94%
Net margin
25.26%

Growth

Even

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
21.55%
33.35%
Profit CAGR (3Y)
32.45%

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.14L Cr
Market cap
₹7,129 Cr
₹25,229 Cr
Revenue
₹828 Cr
₹2,003 Cr
Net profit
₹209 Cr
0.90
Debt / equity
0.00
Apollo Hospitals Enterprise Limited
  • + ["Company has delivered good profit growth of 71.1% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
  • − ["Stock is trading at 11.98 times its book value"]
Supriya Lifescience Limited
  • + ["Company is almost debt free.", "Company has delivered good sales growth of 16.2% CAGR over last 5 years"]
  • − ["Stock is trading at 5.95 times its book value"]
Apollo Hospitals Enterprise Limited full analysis Supriya Lifescience Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.